Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04398719 · ClinicalTrials.gov registry record · Early Phase 1

CBD-Microglia PET Study

A Early Phase 1 study of Healthy and CBD, sponsored by Yale University.

Recruiting
Registry status
Early Phase 1
Development phase
15
Enrollment target
1
Study location

NCT04398719 is a Early Phase 1 study of Healthy and CBD that is actively recruiting participants, run by Yale University. The registered enrollment target is 15 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04398719, a Early Phase 1 study of Healthy and CBD, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Early Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

Conditions Studied

Healthy CBD

Interventions

  • RADIATION [11C]PBR28
  • DRUG Low-dose lipopolysaccharide
  • DRUG Intradermal Capsaicin

Study Locations (1)

Connecticut

  • Connecticut Mental Health Center - New Haven

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-05-07
Est. Completion 2025-09-30
Phase Early Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04398719

The ClinicalTrials.gov registry entry for NCT04398719 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which [11C]PBR28 is the first listed.

NCT04398719 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04398719 about?

NCT04398719 is a clinical study titled "CBD-Microglia PET Study". This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

What is the current status of trial NCT04398719?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2021-05-07. Estimated completion is 2025-09-30.

What conditions does trial NCT04398719 study?

This clinical trial studies the following conditions: Healthy, CBD.

What interventions are being tested in trial NCT04398719?

The interventions under investigation include: [11C]PBR28 (RADIATION), Low-dose lipopolysaccharide (DRUG), Intradermal Capsaicin (DRUG).

Who is sponsoring clinical trial NCT04398719?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04398719 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

CBD

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.